Cerebain Biotech Corp (CBBT) 1.0400 $CBBT Cerebain

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cerebain Biotech Corp (CBBT) 1.0400 $CBBT

Cerebain Biotech and Mossakowski Medical Research Centre Sign Memorandum of Understanding
BusinessWire - Thu Jun 23, 7:30AM CDT
Cerebain Biotech (OTCQB: CBBT) today announced that they signed a Memorandum of Understanding with the Department of Neurodegenerative Diseases, Mossakowski Medical Research Centre in Poland. The purpose of the Memorandum of Understanding is to commence testing of Cerebain's Medical Device once development is completed.

Governor Scott McCallum, Representing Cerebain Biotech, to Present at US-Poland Health Care Summit
BusinessWire - Wed Jun 01, 7:25AM CDT
Cerebain Biotech (OTCQB: CBBT) today announced that Governor Scott McCallum, former governor of Wisconsin, has received an invitation and will be participating in a US-Poland Health Care Summit. The conference will begin on June 17, 2016 and be held in Warsaw, Poland.

CORRECTING and REPLACING Cerebain Biotech Today Announced It Plans to Seek FDA Approval
BusinessWire - Tue May 03, 3:09PM CDT
In fourth paragraph of release dated April 27, 2016, the former Governor of Wisconsin should read: Scott McCallum (instead of Scott Walker).

Cerebain Biotech Today Announced It Plans to Seek FDA Approval
BusinessWire - Wed Apr 27, 7:15AM CDT
Cerebain Biotech (OTCQB: CBBT) today announced that the company intends to seek FDA approval in conjunction with the development and testing of its medical device for the treatment of Alzheimer's and Dementia.

Cerebain Biotech Appoints Dr. Azad L. Sheikh to Scientific Advisory Board
BusinessWire - Mon Apr 11, 7:32AM CDT
Cerebain Biotech (OTCQB: CBBT) today announced that the company has appointed Azad L. Sheikh, MBBS, MRCP (UK), FRCP (C), MBA, to its Scientific Advisory Board.

Cerebain Biotech Presents Corporate Update on Its War against Alzheimer's and Dementia
BusinessWire - Tue Nov 17, 9:48AM CST
Cerebain Biotech (OTCQB: CBBT) today announced that the executive team of Cerebain Biotech Corp. is very pleased to provide an update on the progress made over the last year and an outlook of 2016.

Cerebain Biotech to sell up to 1.6m shares of its stock to GMEA
M2 - Tue Jun 09, 5:45AM CDT
Medical device company Cerebain Biotech (OTCBB:CBBT) disclosed on Monday that it has entered into an agreement to sell up to 1,600,000 shares of its stock to GMEA (Geronimo Middle East and Africa).

Cerebain Biotech Receives Financial Commitment of Two Million Dollars
BusinessWire - Mon Jun 08, 7:30AM CDT
Cerebain Biotech (OTCQB: CBBT) today announced that the company has executed an agreement with GMEA (Geronimo Middle East and Africa) to purchase up to One Million Six Hundred Thousand (1,600,000) shares of the company's stock. These funds will be used to support financial and business development goals that will help the company accelerate its research and testing programs, currently focused on the development of a new treatment in the fight against Alzheimer's Disease.

Cerebain Biotech Appoints Mustafa Husain, M.D., to Scientific Advisory Board
BusinessWire - Thu Jan 29, 6:30AM CST
Cerebain Biotech (OTCQB: CBBT) today announced that the company has appointed Mustafa Husain, M.D., to its Scientific Advisory Board. Dr. Husain is a preeminent researcher with expertise in device-based research for Neuropsychiatric Disorders.

Scott McCallum, Former Wisconsin Governor, Engaged by Cerebain Biotech as Special Advisor
BusinessWire - Thu Dec 04, 6:30AM CST
Cerebain Biotech (OTCQB: CBBT) today announced that the company has engaged Scott McCallum, former governor of Wisconsin, entrepreneur and present Counsel on International Government to Hamilton Advisors, as a special advisor. Cerebain is an early-stage research and development company focused on evaluating a novel approach to the treatment of Alzheimer's Disease. Governor McCallum will serve as an invaluable resource in supporting rapid growth for the company as omental stimulation, the focus of Cerebain's research, is formally launched for study in Europe and then the United States.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Updated Category News Views 32

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

Continue Reading
Truck Drivers USA & Career Driver Unveil New Driver Agent

Updated Category News Views 41

Revolutionizing Driver-Carrier Connections In today's cranking transportation scene, Truck Drivers USA (TDUSA) and Career Driver have taken a bold step to change up the driver recruitment game. They've launched what's being labeled as the first 'driver agent' within the Career Driver mobile app. It's the talk of the town in Sherwood, Arkansas, these days. This isn't just...

Continue Reading
Omega Point's MCP Secures Anthropic Verification

Updated Category News Views 25

In a world where investment decisions ride on razor-thin margins, Omega Point's MCP gains top-tier verification. Anthropic's seal of approval is stamped firmly on it, signalling to the wise investors out there that this engine ain't smoking mirrors. Since May, this player has been doing the rounds, but now, with Anthropic’s verification, it’s like Omega Point just...

Continue Reading
Jaguar Promise Tackles College Cost for Texas Students

Updated Category News Views 25

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

Continue Reading
Puori Protein Transparency Pays Off Amid Lead Scare

Updated Category News Views 19

Puori's Moment of Reckoning The world of nutritional supplements is no stranger to controversy, but when Puori found itself caught in the storm of the Consumer Reports investigation last year, it chose a road less traveled: transparency and accountability. Faced with alarming news that over two-thirds of tested protein powders exceeded California's Proposition 65 lead...

Continue Reading
JiMMYBAR! Unveils World's First Creatine Trail Mix

Updated Category News Views 25

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Continue Reading
Marshall Goldman Expands Footprint with Marino Acquisition

Updated Category News Views 40

Revving Up in Florida: Marshall Goldman's Strategic Leap If you're tuned into the luxury car scene, you probably already heard Marshall Goldman is making moves into Florida. Buying Marino Performance Motors of West Palm Beach isn't just another notch on their belt—it's a strategic leap into their second-largest market. This ain't merely about showroom floor space. Think...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 23

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading
FCS Drives Key FDA Approvals in Cancer Treatment

Updated Category News Views 28

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Continue Reading
WIN Expands Leadership Amidst Rapid Growth Surge

Updated Category News Views 30

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...

Continue Reading

Top 5 Most Recently Viewed Articles

Imac Holdings Navigates Troubling Times and Financial Strains

Updated Category News Views 309

Imac Holdings Faces 52-Week Low in Turbulent Market Imac Holdings Inc (NASDAQ: IMAC) is experiencing significant challenges as its stock price has hit a 52-week low of $0.96. This decline represents a staggering 52.36% drop in its stock value over the past year. Investors are feeling the pressure as the company fights against an array of market adversities. The current...

Continue Reading
Kiniksa Pharmaceuticals' Upgraded Price Target Sparks Interest

Updated Category News Views 81

Kiniksa Pharmaceuticals Receives Price Target Upgrade Recently, Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) experienced a surge in interest following Evercore ISI's adjustment of its price target on the company’s stock. The new target is set at $35, an increase from the previous $30, and comes alongside a retained Outperform rating. This update is a positive reflection...

Continue Reading
Investigation Launched into American Woodmark Corporation Sale

Updated Category News Views 196

New Investigation Announced for American Woodmark Corporation Recently, attention has been drawn to American Woodmark Corporation (NASDAQ: AMWD) as a class action law firm starts investigating the terms of its proposed sale to MasterBrand, Inc. This investigation arises from the concern that the sale may not be beneficial for shareholders, presenting questions about...

Continue Reading
Virax Biolabs' Strategic Direction and Innovations for 2026

Updated Category News Views 202

Virax Biolabs' Commitment to Innovation and Progress Virax Biolabs' proprietary diagnostic technology targets post-acute infection syndromes (PAIS), including the challenging Long COVID. This year is critical for data emergence, especially after numerous clinical milestones achieved recently. Virax Biolabs Group Limited (NASDAQ: VRAX), a pioneering biotechnology firm, has...

Continue Reading
Aebi Schmidt Group Declares Historic Dividend Following Nasdaq Listing

Updated Category News Views 123

Aebi Schmidt Group Makes History with First Dividend Payment Aebi Schmidt Group (NASDAQ: AEBI) has taken a monumental step in its journey by declaring its first-ever dividend payout. As a leader in the specialty vehicles sector, this announcement marks a significant milestone for the company. Details of the First Dividend The company’s decision follows its successful...

Continue Reading